Redona Therapeutics

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OrsoBio Splurges With Four Concurrent L

The pace of public company financings by cell and gene therapy developers slowed in the first quarter versus the prior two years, according to a new report from the Alliance for Regenerative Medicine

In a summer slowdown, biopharmaceutical start-up fundraising declined 27% in the third quarter of 2018, but Gossamer Bio Inc. and Orchard Therapeutics Ltd. brought in large venture capital rounds

AbCellera Secures $10m Series A Investment AbCellera Biologics Inc. raised $10m in its Series A financing round led by DCVC Bio, which adds 2 board seats. (Sep.) Founded in 2012 based on microfluidi